Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease (Q42494887)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

1 November 2017

Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease (English)

1 reference

Europe PubMed Central

1 November 2017

Alzheimer's disease

0 references

mild cognitive impairment

1 reference

based on heuristic

inferred from title

cognitive dysfunction

1 reference

based on heuristic

inferred from title

Elliott J Mufson

1

object named as

Mufson EJ

1 reference

Europe PubMed Central

1 November 2017

Jeffrey H Kordower

8

object named as

Kordower JH

1 reference

Europe PubMed Central

1 November 2017

David A Bennett

4

object named as

Bennett DA

1 reference

Europe PubMed Central

1 November 2017

author name string

Ma SY

2

1 reference

Europe PubMed Central

1 November 2017

Cochran EJ

3

1 reference

Europe PubMed Central

1 November 2017

Beckett LA

5

1 reference

Europe PubMed Central

1 November 2017

Jaffar S

6

1 reference

Europe PubMed Central

1 November 2017

Saragovi HU

7

1 reference

Europe PubMed Central

1 November 2017

language of work or name

0 references

publication date

1 November 2000

1 reference

Europe PubMed Central

1 November 2017

The Journal of Comparative Neurology

1 reference

Europe PubMed Central

1 November 2017

427

1 reference

Europe PubMed Central

1 November 2017

1

1 reference

Europe PubMed Central

1 November 2017

19-30

1 reference

Europe PubMed Central

1 November 2017

Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

The cholinergic hypothesis of geriatric memory dysfunction

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Around the WORLD backward: an algorithm for scoring the MMSE WORLD item.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Dimensionality of parkinsonian signs in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Visuospatial judgment. A clinical test

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Keeping track of neurotrophin receptors

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Trk receptor alterations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Incidental and intentional recall in Parkinson's disease: an account based on diminished attentional resources.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Cholinergic markers in elderly patients with early signs of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Questionable dementia: clinical course and predictors of outcome.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Mild cognitive impairment in the elderly: predictors of dementia

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

In situ hybridization detection of trkA mRNA in brain: distribution, colocalization with p75NGFR and up-regulation by nerve growth factor

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Is Alzheimer disease caused by lack of nerve growth factor?

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

trk-immunoreactivity in the monkey central nervous system: forebrain

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Correlation between neuromorphometry in the substantia nigra and clinical features in Parkinson's disease using disector counts.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Nerve growth factor-like immunoreactive profiles in the primate basal forebrain and hippocampal formation

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Induction of apoptosis by the low-affinity NGF receptor

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Very mild senile dementia of the Alzheimer type. I. Clinical assessment.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Reduction in TrkA-immunoreactive neurons is not associated with an overexpression of galaninergic fibers within the nucleus basalis in Down's syndrome

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Presynaptic cholinergic dysfunction in patients with dementia.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Neuronal counts in basal nucleus of Meynert in Alzheimer disease and in simple senile dementia

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Dementia. A brief and selective review

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Cognitive functions of the basal forebrain cholinergic system in monkeys: memory or attention?

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

New stereological methods for counting neurons

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Plaques, tangles and dementia. A quantitative study.

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Change in cognitive function in older persons from a community population: relation to age and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2F1096-9861%2820001106%29427%3A1%3C19%3A%3AAID-CNE2%3E3.0.CO%3B2-A

21 January 2018

Identifiers

10.1002/1096-9861(20001106)427:1<19::AID-CNE2>3.0.CO;2-A

1 reference

Europe PubMed Central

1 November 2017

1 reference

Europe PubMed Central

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42494887&oldid=2100771237"